Cardiovascular safety profile of duloxetine in patients with diabetic peripheral neuropathic pain

被引：0
|
作者：
Kajdasz, D. K.
Walker, D. J.
Raskin, J.
Wernicke, J. F.
Skljarevski, V.
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Eli Lilly Canada, Lilly Res Labs, Scarborough, ON, Canada
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [21] A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
    Wernicke, J. F.
    Pritchett, Y. L.
    D'Souza, D. N.
    Waninger, A.
    Tran, P.
    Iyengar, S.
    Raskin, J.
    NEUROLOGY, 2006, 67 (08) : 1411 - 1420
  • [22] The relationships between sleep and pain in patients with diabetic peripheral neuropathic pain: Responses to treatment with duloxetine
    Fishbain, D. A.
    Hall, J.
    Meyers, A.
    Gonzales, J.
    Whitmyer, V.
    Thompson, H.
    Skljarevski, V.
    Mallinckrodt, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 270 - 270
  • [23] Comparison of the Efficacy and Safety of Duloxetine and Gabapentin in Diabetic Peripheral Neuropathic Pain: A Meta-Analysis
    Jiang, Lanying
    Xiong, Yadan
    Cui, Jinguo
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [24] A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
    Shah, Islam
    Ahmad, Wiqas
    Islam, Muhammad
    Jan, Bakhti
    Ul Haq, Ejaz
    Mahmood, Jawad
    Iqbal, Nasir
    Shah, Mustaqeem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [25] Safety and efficacy of duloxetine in the treatment of diabetic peripheral pain in elderly patients
    Wernicke, J. F.
    Wasan, A. D.
    Ossanna, M. J.
    Raskin, J.
    Robinson, M. J.
    Hall, J. A.
    Edwards, S. E.
    Lipsius, S.
    Meyers, A. L.
    McCarberg, B. H.
    DIABETOLOGIA, 2008, 51 : S504 - S504
  • [26] DULOXETINE THERAPY AND CHANGES IN OPIOID USE AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS
    Wu, N.
    Zhao, Y.
    Boulanger, L.
    Fraser, K.
    Chen, S. Y.
    VALUE IN HEALTH, 2009, 12 (03) : A107 - A107
  • [27] The efficacy of duloxetine in reducing pain behavior in animal models of neuropathic pain accurately predicted the efficacy of duloxetine in diabetic peripheral neuropathic pain
    Hall, J. A.
    Iyengar, S.
    Perahia, D. G. S.
    Robinson, M. J.
    Ferdinand, S. J.
    Andorn, A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 98 - 99
  • [28] COMPARISON OF DOSING PATTERNS OF DULOXETINE AND PREGABALIN AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN
    Sun, P.
    Zhao, Y.
    Bledsoe, S.
    Watson, P. R.
    VALUE IN HEALTH, 2009, 12 (03) : A98 - A98
  • [29] Comparing the safety and tolerability of duloxetine for the management of diabetic peripheral neuropathic pain (DPNP) between patients with and without historical and/or co-morbid cardiovascular conditions
    Wernicke, Joachim
    Prakash, Apurva
    Kajdasz, Daniel
    Houston, John
    DIABETES, 2007, 56 : A557 - A558
  • [30] Review of Efficacy and Safety of Duloxetine 40 to 60mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
    Skljarevski, Vladimir
    Frakes, Elijah P.
    Sagman, Doron
    Lipsius, Sarah
    Heinloth, Alexandra N.
    Duenas Tentori, Hector J.
    PAIN RESEARCH AND TREATMENT, 2012, 2012
12345